101 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|
102 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|
103 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|
104 |
Forest Laboratories, LLC et al v. Mylan Pharmaceuticals Inc. |
1:17-cv-01728 |
D.Del. |
|
|
|
|
105 |
Forest Laboratories, LLC et al v. Mylan Pharmaceuticals Inc. |
1:17-cv-01728 |
D.Del. |
|
|
|
|
106 |
Forest Laboratories, LLC et al v. Mylan Pharmaceuticals Inc. |
1:17-cv-01728 |
D.Del. |
|
|
|
|
107 |
Forest Laboratories, LLC et al v. Mylan Pharmaceuticals Inc. |
1:17-cv-01728 |
D.Del. |
|
|
|
|
108 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
109 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
110 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
111 |
Gilead Sciences, Inc. v. Mylan Pharmaceuticals Inc. |
1:17-cv-00217 |
N.D.W.Va. |
|
|
|
|
112 |
Gilead Sciences, Inc. v. Mylan Pharmaceuticals Inc. |
1:17-cv-00187 |
D.Del. |
|
|
|
|
113 |
Indivior Inc. et al v. Mylan Technologies Inc. et al |
1:17-cv-00157 |
N.D.W.Va. |
|
|
|
|
114 |
Indivior Inc. et al v. Mylan Technologies Inc. et al |
1:17-cv-00157 |
N.D.W.Va. |
|
|
|
|
115 |
Gilead Sciences, Inc. v. Mylan Pharmaceuticals Inc. |
1:17-cv-00036 |
N.D.W.Va. |
|
|
|
|
116 |
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:16-cv-01114 |
D.Del. |
|
|
|
|
117 |
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:16-cv-01114 |
D.Del. |
|
|
|
|
118 |
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:16-cv-01114 |
D.Del. |
|
|
|
|
119 |
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:16-cv-01114 |
D.Del. |
|
|
|
|
120 |
Takeda Pharmaceuticals U.S.A, Inc. v. Mylan Pharmaceuticals, Inc. |
1:16-cv-00202 |
N.D.W.Va. |
|
|
|
|
121 |
Gilead Sciences Inc. v. Mylan Pharmaceuticals Inc. |
1:16-cv-00192 |
D.Del. |
|
|
|
|
122 |
Cosmo Technologies Limited et al v. Mylan Pharmaceuticals Inc. |
1:16-cv-00040 |
N.D.W.Va. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
123 |
Cosmo Technologies Limited et al v. Mylan Pharmaceuticals Inc. |
1:16-cv-00040 |
N.D.W.Va. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
124 |
Cosmo Technologies Limited et al v. Mylan Pharmaceuticals Inc. |
1:16-cv-00040 |
N.D.W.Va. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
125 |
ASTRAZENECA PHARMACEUTICALS LP et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-07009 |
D.N.J. |
|
|
|
|
126 |
ASTRAZENECA PHARMACEUTICALS LP et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-07009 |
D.N.J. |
|
|
|
|
127 |
ASTRAZENECA PHARMACEUTICALS LP et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-07009 |
D.N.J. |
|
|
|
|
128 |
ABBVIE INC. et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-01402 |
N.D.Ill. |
|
|
|
|
129 |
ABBVIE INC. et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-01402 |
N.D.Ill. |
|
|
|
|
130 |
ABBVIE INC. et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-01402 |
N.D.Ill. |
|
|
|
|
131 |
AstraZeneca LP et al v. Mylan Pharmaceuticals Inc. |
1:15-cv-00999 |
D.Del. |
|
|
|
|
132 |
AstraZeneca LP et al v. Mylan Pharmaceuticals Inc. |
1:15-cv-00999 |
D.Del. |
|
|
|
|
133 |
AstraZeneca LP et al v. Mylan Pharmaceuticals Inc. |
1:15-cv-00999 |
D.Del. |
|
|
|
|
134 |
AstraZeneca LP et al v. Mylan Pharmaceuticals Inc. |
1:15-cv-00999 |
D.Del. |
|
|
|
|
135 |
Teva Pharmaceuticals USA, Inc. et al v. Doctor Reddy's Laboratories Ltd. et al |
1:15-cv-00306 |
D.Del. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
136 |
Teva Pharmaceuticals USA, Inc. et al v. Doctor Reddy's Laboratories Ltd. et al |
1:15-cv-00306 |
D.Del. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
137 |
Teva Pharmaceuticals USA, Inc. et al v. Doctor Reddy's Laboratories Ltd. et al |
1:15-cv-00306 |
D.Del. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
138 |
Teva Pharmaceuticals USA, Inc. et al v. Doctor Reddy's Laboratories Ltd. et al |
1:15-cv-00306 |
D.Del. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
139 |
GILEAD SCIENCES, INC. et al v. Mylan Inc. et al |
1:15-cv-00149 |
N.D.W.Va. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
140 |
GILEAD SCIENCES, INC. et al v. Mylan Inc. et al |
1:15-cv-00149 |
N.D.W.Va. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
141 |
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00145 |
N.D.W.Va. |
|
|
|
|
142 |
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00145 |
N.D.W.Va. |
|
|
|
|
143 |
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00145 |
N.D.W.Va. |
|
|
|
|
144 |
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00145 |
N.D.W.Va. |
|
|
|
|
145 |
Janssen Biotech, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00130 |
N.D.W.Va. |
|
|
|
|
146 |
Janssen Biotech, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00130 |
N.D.W.Va. |
|
|
|
|
147 |
Janssen Biotech, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00130 |
N.D.W.Va. |
|
|
|
|
148 |
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. |
1:15-cv-00013 |
N.D.W.Va. |
|
|
|
|
149 |
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. |
1:15-cv-00013 |
N.D.W.Va. |
|
|
|
|
150 |
OTSUKA PHARMACEUTICAL CO., LTD. v. MYLAN INC. et al |
1:14-cv-04508 |
D.N.J. |
|
|
|
|